Varian Medical Systems
3100 Hansen Way
Palo Alto
California
94304
United States
Tel: (650) 213-8000
Fax: 650-842-5196
Website: http://www.varianinc.com/cgi-bin/nav?/
Email: custserv@varianinc.com
702 articles about Varian Medical Systems
-
Telix Pharmaceuticals Enters Strategic Collaboration with Varian Medical Systems for Advanced Prostate Imaging - Sep 03, 2020
9/3/2020
Telix Pharmaceuticals Limited announced it has entered into a strategic collaboration agreement with Palo Alto-based Varian Medical Systems, to evaluate the use of advanced prostate cancer imaging within Varian’s radiation treatment planning platform.
-
As the largest center for biotech startups in the U.S., the Boston/Cambridge, Massachusetts area often acts as a marker for the entire industry. Here’s a look at the Massachusetts M&A deals so far.
-
Varian Announces Definitive Agreement to Acquire Cancer Treatment Services International
5/20/2019
Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems announced it has entered into a definitive agreement to acquire Cancer Treatment Services International for $283 million.
-
The San Francisco Business Times came out with a list of 64 major Bay Area employers and their median pay, which they then compared to their chief executives’ annual compensation.
-
The deal expands the company's Quality Assurance tool portfolio.
-
Varian will pay A$28 per share in cash for the Australian medtech.
-
Dow R. Wilson to Join Agilent’s Board of Directors
1/19/2018
Agilent Technologies Inc. today announced that Dow R. Wilson, CEO of Varian Medical Systems, has been elected to its board of directors, effective March 20, 2018.
-
Varian Medical Announces First Quarter Fiscal Year 2018 Earnings Release Date
12/13/2017
Varian today announced that it will report results for the first quarter of fiscal year 2018 after market close on Wednesday, January 24, 2018.
-
Varian Medical Schedules Annual Stockholder Meeting in Palo Alto
11/29/2017
Varian Medical Systems announced today that its Board of Directors has scheduled the 2018 Annual Meeting of Stockholders for February 8, 2018 with a record date of December 11, 2017.
-
Varian Announces Opening of New Facility in Brazil
11/21/2017
In 2018 the manufacturing and warehousing areas of the facility will become operational.
-
Varian Halcyon Treatment System Receives Shonin Approval
11/16/2017
Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy.
-
The Delta4 Discover Transmission Detector, a State-of-the-Art 4D in-Vivo Dosimetry System From ScandiDos, is Now Approved for Use by Varian Medical Systems on TrueBeam and Clinac Systems
11/16/2017
ScandiDos AB and Varian Medical Systems have completed verification and validation of the Delta4 Discover system for use on TrueBeam and Clinac Ix radiotherapy systems [15-November-2017] UPPSALA, Sweden, Nov. 15, 2017 /PRNewswire/ -- ScandiDos AB (NASDAQ OMX First North: SDOS), a global leader in Quality Assurance (QA) and dosimetry for modern radiation thera
-
DNAmito to Integrate Genomics-Based Personalized Analysis With Varian's Oncology Care Management Software Platform to Optimize Physician's Decisions Regarding Radiation Treatment for Cancer
11/16/2017
DNAmito and Varian Medical Systems announced today a development and OEM agreement to integrate Prodecis into Varian's 360 Oncology care management software platform.
-
Varian Inks $50M Multi-Year Project Deal
11/6/2017
The company secured a deal to equip Rigshospitalet and Herlev Hospital with modern treatment systems over the next few years. -
Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems
11/6/2017
reatments delivered using linear accelerators including Algeria's first TrueBeam systems are being delivered at Sidi-Bel-Abbes and Tlemcen Hospitals in the west of the country.
-
Global Availability of Varian Halcyon Treatments Expands with First Cancer Patient Treated in Australia
11/1/2017
Varian Medical Systems announced a 71-year-old male with prostate cancer became the first patient in Australia to be treated on the Halcyon system at ROC in Toowoomba by Brisbane-based Icon Group.
-
Varian Names New Chief People Officer, SVP HR
10/30/2017
Varian today announced it has named Terilyn Juarez Monroe as Chief People Officer, senior VP, Human Resources effective October 30, 2017.
-
Varian Selected to Provide Proton System and Software for Oncology Hospital in South China
10/26/2017
Varian today announced it has been selected to install a ProBeam four-room proton therapy system in the new Guangzhou Concord Cancer Hospital.
-
Varian Reports Results for Fourth Quarter of Fiscal Year 2017
10/26/2017
Varian today announced its fourth-quarter and full-year fiscal 2017 results.
-
Varian Compact Single-room Proton Therapy System Selected by Penn Medicine for New Treatment Center
10/26/2017
Varian today announced it has been selected by Penn Medicine to install a Varian ProBeam Compact single-room proton therapy system in a new cancer treatment center.